Category : Search result: pharmaceutical revenue


Health Canada Approves Drug for Rare Disease

Health Canada has granted approval for a new pharmaceutical treatment targeting a rare disease, offering hope for patients. Learn about the regulatory decision and its impact.

Pfizer 2026 profit forecast below expectations

Pfizer projects 2026 profits below Wall Street estimates due to a steep drop in COVID product sales and loss of exclusivity for key drugs. Get the full business analysis.

CRA warns of aggressive tax schemes in Canada

The Canada Revenue Agency has issued a public alert about aggressive tax avoidance schemes operating in the country. Learn what to watch for and how to protect yourself.

Delta Air Lines lost $200M in U.S. shutdown

The longest U.S. government shutdown cost Delta Air Lines an estimated $200 million in revenue. The airline cites reduced travel demand from federal employees and contractors.

China's Biopharma Surge Challenges Global Drug Leaders

China's biopharma industry is accelerating, fueled by record investment and streamlined supply chains. With faster development times and massive deals like AstraZeneca's $5.2B pact, the global drug innovation race is heating up. Discover the shift from ou

Eli Lilly cuts price of obesity drug Zepbound

Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.

Economist Calls Trump's Economic Claims 'Nonsense'

University of Michigan economist Justin Wolfers dismantles Donald Trump's recent economic boasts, calling them misleading and highlighting weak consumer confidence. Read the full analysis.

Grey Bruce drug disposal nets meds for hockey tickets

Grey Bruce residents exchanged unused pharmaceuticals for Barrie Colts hockey tickets in a successful medication safety initiative. Learn how this program helps combat opioid misuse and environmental contamination.

Dipharma's Novel Method Detects Nitrosamine Risks

Dipharma publishes a peer-reviewed study unveiling a novel method to detect and characterize nitrosamine impurities in Active Pharmaceutical Ingredients, enhancing drug safety and regulatory compliance.

Canada's cannabis tax revenue tops $5.4 billion

Federal and provincial governments have collected over $5.4 billion in cannabis tax revenue since legalization. Discover how this revenue is impacting Canadian communities and the economy.

Novo Nordisk Alzheimer's Drug Trials Fail

Danish pharmaceutical giant Novo Nordisk faces major setback as Alzheimer's drug trials fail. Learn how this impacts the weight-loss leader's expansion plans.

Page 1 of 3